Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Scheduled Trading Statement

15 Dec 2016 07:00

RNS Number : 8880R
Xaar PLC
15 December 2016
 

15 December 2016

 

Xaar plc

 

Scheduled Trading Statement

 

Xaar plc ("Xaar", "the Group" or "the Company"), the digital inkjet printing technology Group headquartered in Cambridge, UK, announces an update on trading for the period beginning 1 July 2016. 

The Board now expects total revenue in the second half of 2016 to be similar to the £44.5 million recorded in the first six months of the year, before taking account of revenue delivered by the acquired EPS business which contributed to the Group from 1 July 2016. The Board's expectation for overall full year earnings remains unchanged.

In ceramic tile printing ("Ceramics"), initial demand for Xaar's new 2001 and 2001+ printheads is strong following the launch of those products in September. Longer than expected customer printer re-designs and manufacturing ramp up, combined with the competitive pressures we have previously highlighted in this sector, are expected to result in lower Ceramics sales in the second half of 2016 than previously anticipated. The products launched this year position the Company well in terms of maintaining Xaar's market leading position and supporting our OEM partners in 2017 and beyond.

In Packaging and Product Printing, sales are ahead of expectations. All packaging sub-sectors, including labels, coding & marking and direct to shape, are delivering organic growth ahead of both H1 2016 and H2 2015 sales. Engineered Printing Solutions ("EPS"), the US product printing equipment company acquired on 1 July 2016, is performing to plan and a smooth integration into the Xaar Group has been achieved.

Initial demand is high from our partner OEMs for the new Thin Film printheads launched this year, the 5601 and the 1201. Both products are on track to provide significant revenue contributions in 2017.

Revenue from Xaar's licensing business has again been strong in the second half of 2016, through a combination of favourable exchange rates, higher licensee royalties and a significant royalty audit resolution. Royalty related revenue in the second half of 2016 is therefore expected to be similar to the total recorded in the first six months of the year.

The Company expects to announce its 2016 full year results on 22 March 2017.

This announcement has been determined to contain inside information.

Contacts

 

Xaar plc

Alex Bevis, CFO

+44 (0)1223-423663

Doug Edwards, CEO

www.xaar.com

Tulchan Communications

James Macey White

 

+44 (0)20-7353-4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDZLFFQLFXFBX
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.